Hani Al Salami

Assoc Prof Hani Al-Salami

RegPharmNZ, RegPharmAus, MPS, ANZCP
Head of Hearing Therapeutics


Genius is 1% talent and 99% hard work” Albert Einstein

Associate Professor Hani Al-Salami is an AHPRA registered Australian and New Zealand pharmacist, a clinician, an academic, and a Program Lead in Biotechnology and Pharmaceutical Sciences at Curtin Medical School and Curtin Health Innovation Research Institute.

In November 2020, Dr Al-Salami’s team was declared the overall winner at the Curtin Innovation Program for most innovative inner-ear drug delivery for treating hearing loss. Dr Al-Salami, originally from New Zealand, was trained at the School of Pharmacy, Otago University, and owned a Dunedin-based pharmacy prior to commencing a doctorate supported by the pharmaceutical industry. He moved to Montreal (Canada) for postdoctoral training at the Artificial Cell and Organs Research Centre at McGill University jointly with the drug company Micropharma Ltd, under Prof Thomas Chang and Prof Satya Prakash (nano/microencapsulation pioneers and nominated Nobel Prize Laureate in medicine).

Dr Al-Salami moved to Curtin University where he founded his lab, the Biotechnology and Drug Development Research Lab (2014). He has published > 150 publications and conference presentations, including books, book chapters and research papers. Dr Al-Salami research is currently supported by the Australian Medical Health Research Council, the European Horizon 2020, Cures Within Reach (USA), and the pharmaceutical industry nationally and internationally (Australia, China, and the EU).

Areas of research

Drug discovery, bio-nanotechnologies and pharmaceutical sciences

Top publications

Susbin Raj Wagle, Božica Kovačević, Daniel Walker, Corina Mihaela Ionescu, Melissa Jones, Goran Stojanovic, Sanja Kojic, Armin Mooranian, Hani Al-Salami. Pharmacological and Advanced Cell Respiration Effects, Enhanced by Toxic Human-Bile Nano-Pharmaceuticals of Probucol Cell-Targeting Formulations. Pharmaceutics 2020, 12(8), 708; https://doi.org/10.3390/pharmaceutics12080708

Susbin Wagle, Bozica Kovacevic, Daniel Walker, Corina Ionescu, Umar Zahoor, Goran Stojanovic, Sanja Kojic, Armin Mooranian, Hani Al-Salami. Alginate-based drug oral targeting using bio-micro/nano encapsulation technologies. Expert Opinion on Drug Delivery, in press

Susbin Raj Wagle, Daniel Walker, Bozica Kovacevic, Ahmed Gedawy, Momir Mikov, Svetlana Golocorbin-Kon, Armin Mooranian, Hani Al-Salami. Micro-Nano formulation of bile-gut delivery: rheological, stability and cell survival, basal and maximum respiration studies. Scientific Reports, 10:7715 | https://doi.org/10.1038/s41598-020-64355-z

Armin Mooranian, Nassim Zamani, Momir Mikov, Svetlana Goločorbin-Kon, Goran Stojanovic, Frank Arfuso, Bozica Kovacevic, Hani Al-Salami. A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds. Saudi Pharmaceutical Journal, doi.org/10.1016/j.jsps.2019.11.017

Mooranian A, Zamani N, Takechi R, Luna G, Mikov M, Goločorbin-Kon S, Elnashar M, Arfuso F, Al-Salami H. An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques. PLoS One. 2019 Apr 4;14(4):e0214984. doi: 10.1371/journal.pone.0214984.

Read more on Hani Ali-Salami

Google Scholar